Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Daniel DO-Dai

Diagnostic Radiology Grand Rapids, MI Medical Doctor

NPI 1326049727 CMS profile 1084149

3264 N Evergreen Dr Ne, Grand Rapids, MI 49525

Open in the dashboard

General payments

$14,606

14 records reported · program years 2019–2025

Research payments

$19,046

Paid to them · 8 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$22,521 paid to institutions, not to them · program years 2021–2024

Through program year 2025, Daniel DO-Dai of Grand Rapids, MI is reported in the CMS Open Payments database as having received $14,606 across 14 general payments and $19,046 in research payments paid to them. Separately, studies naming them as principal investigator received $22,521 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 Research $952 4
2021 General $9,203 7
2020 Research $18,094 4
2019 General $5,404 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daniel DO-Dai
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Daniel DO-Dai were reported at $0. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Daniel DO-Dai Diagnostic Radiology median Middle half National median
2019 $5,404 $108 $29–$318 $163
2020 $0 $65 $21–$252 $114
2021 $9,203 $92 $24–$292 $132
2022 $0 $104 $29–$294 $149
2023 $0 $110 $29–$337 $160
2024 $0 $113 $30–$356 $164
2025 $0 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Merck Sharp & Dohme Corporation $9,203 7 payments
  2. Dynavax Technologies Corporation $5,390 6 payments
  3. Alexion Pharmaceuticals, Inc. $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $14,593 13 payments
  2. Food and Beverage $14 1 payment
Products named General payments · program years 2019–2025
  1. LENVIMA $9,203 7 payments
  2. Heplisav-B $5,390 6 payments
  3. Soliris $14 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Guerbet LLC $18,094 4 payments
  2. Regeneron Pharmaceuticals, Inc. $952 4 payments

Billing to Medicare

Part B · data year 2024 · 76 billing codes

Paid by Medicare

$81,858

Medicare's payments for the services billed

Medicare patients

1,090

Average age 73

Services billed

1,695

612 women, 478 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 58%
Ischemic heart disease 39%
Diabetes 37%
Depression 36%
Chronic kidney disease 35%
Atrial fibrillation 30%
Heart failure 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

22 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record